Abstract
The bioavailability of coenzyme Q 10 (CoQ 10 ) in various pharmaceutical formulations (solutions and tablets) containing solubilized CoQ 10 in comparison to lipophilic powder of CoQ 10 has been studied in rats. It is established that the bioavailability of solubilized CoQ 10 in tablets and solution after peroral administration is higher than that of lipophilic CoQ 10 powder. The time to reach peak CoQ 10 concentrations in plasma was shorter for the solution of the solubilized form. Auxiliary swelling substances in tablets prolong and increase the absorption of CoQ 10 .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
